TABLE 2
FROM:
GI complications in pediatric patients post-BMT
C C Barker, R A Anderson, R S Sauve and J D Butzner
BACK TO ARTICLETable 2. Means and standard deviations of the highest hepatic laboratory values recorded post transplantation for the transplants that developed hepatic graft-versus-host disease (GVHD), veno-occlusive disease (VOD) and 'other' (hepatic dysfunction without GVHD or VOD complications)
| Variable | 'Other' hepatic dysfunction (n=90) | Hepatic GVHD (n=24) | Hepatic VOD (n=13) |
|---|---|---|---|
| ALT (IU/l) | 122 149 | 430 987a
| 726 1061a
|
| AST (IU/l) | 125 171 | 311 962a
| 1481 2572a
|
| GGT (IU/l) | 166 205 | 255 140a
| 572 1147a
|
| Alkaline phosphatase (IU/l) | 190 122 | 202 120 | 286 290a
|
Bilirubin ( mol/l) | 22 23 | 49 31a
| 223 226a
,
b
|
The 15 transplants that did not develop any hepatic dysfunction are not recorded in this table.
a A comparison of means between the groups found a significant difference between the 'other' group and the hepatic GVHD or the VOD group (P<0.05).
b A significant difference was found between the hepatic GVHD group and VOD group (P<0.05).

149
mol/l)